Literature DB >> 23940440

Chronic diarrhea as the initial clinical manifestation of light-chain amyloidosis with cardiac involvement despite negative duodenal and rectal biopsies.

Christian Pfluecke1, Stefan Ulbrich, Karim Ibrahim, Kathrin D Geiger, Ruth H Strasser, Carsten Wunderlich.   

Abstract

Early and accurate diagnosis and a prompt initiation of treatment are critical for the prognosis of light-chain amyloidosis. The present article describes a case involving a 62-year-old patient who experienced unexplained, chronic diarrhea with negative duodenal and rectal biopsies. Serum immunofixation, a free light-chain assay, electrocardiography and echocardiography were performed after the patient developed syncope. The results of these diagnostic investigations showed characteristic signs of systemic amyloidosis. Cardiac and bone marrow biopsies confirmed the diagnosis of systemic light-chain amyloidosis. The chronic diarrhea was found to be due to an autonomic neuropathy of the enteric nervous system.

Entities:  

Keywords:  Amyloidosis; Chronic diarrhea; Diastolic heart failure; Infiltrative cardiomyopathy; Peripheral neuropathy; Smoldering plasmacytoma

Year:  2013        PMID: 23940440      PMCID: PMC3718595     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  18 in total

1.  Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Shaji K Kumar; David Dingli; Stephen M Ansell; Dennis A Gastineau; David J Inwards; Patrick B Johnston; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Nelson Leung; William J Hogan; Francis K Buadi
Journal:  Leuk Lymphoma       Date:  2010-10-20

2.  Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis.

Authors:  Sadhna Dhingra; Narendra Krishnani; Niraj Kumari; Rakesh Pandey
Journal:  Acta Cytol       Date:  2007 Nov-Dec       Impact factor: 2.319

Review 3.  Amyloidosis: pathogenesis and new therapeutic options.

Authors:  Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

5.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

6.  Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

Authors:  Giovanni Palladini; Vittorio Perfetti; Laura Obici; Riccardo Caccialanza; Alessandra Semino; Fausto Adami; Giobatta Cavallero; Roberto Rustichelli; Giovambattista Virga; Giampaolo Merlini
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

7.  High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

Authors:  Arnaud Jaccard; Philippe Moreau; Veronique Leblond; Xavier Leleu; Lotfi Benboubker; Olivier Hermine; Christian Recher; Bouchra Asli; Bruno Lioure; Bruno Royer; Fabrice Jardin; Frank Bridoux; Bernard Grosbois; Jérome Jaubert; Jean-Charles Piette; Pierre Ronco; Fabrice Quet; Michel Cogne; Jean-Paul Fermand
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

8.  Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

Authors:  Claudio Rapezzi; Giampaolo Merlini; Candida C Quarta; Letizia Riva; Simone Longhi; Ornella Leone; Fabrizio Salvi; Paolo Ciliberti; Francesca Pastorelli; Elena Biagini; Fabio Coccolo; Robin M T Cooke; Letizia Bacchi-Reggiani; Diego Sangiorgi; Alessandra Ferlini; Michele Cavo; Elena Zamagni; Maria Luisa Fonte; Giovanni Palladini; Francesco Salinaro; Francesco Musca; Laura Obici; Angelo Branzi; Stefano Perlini
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

Review 9.  Perspectives in treatment of AL amyloidosis.

Authors:  Ashutosh D Wechalekar; Philip N Hawkins; Julian D Gillmore
Journal:  Br J Haematol       Date:  2007-12-19       Impact factor: 6.998

Review 10.  Light chain (AL) amyloidosis: update on diagnosis and management.

Authors:  Michael Rosenzweig; Heather Landau
Journal:  J Hematol Oncol       Date:  2011-11-18       Impact factor: 17.388

View more
  1 in total

1.  Chronic Diarrhea as the Presenting Feature of Amyloidosis with Multiple Myeloma: A Case Report Diagnosed by a Myocardial Biopsy.

Authors:  Shinsuke Otagiri; Sae Nakajima; Takehiko Katsurada; Kensuke Sakurai; Kana Yamanashi; Takahide Ara; Emi Takakuwa; Tomoko Mitsuhashi; Naoya Sakamoto
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.